Lifestyle-related diseases
Conditions
Interventions
The intervention group will receive a three-month health guidance program using ICT, along with questionnaire surveys and measurements of weight, waist circumference, and urinary natriuretic peptide r
Sponsors
Institute of Science Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Employees who are 40 years of age or older and 65 years of age or younger at the time of obtaining consent. 2) Individuals capable of independently performing the operations and wearing the ICT devices required for the study. 3) BMI of 25 or higher 4) Individuals who, based on their health examination results, meet at least one of the following risk factors for metabolic syndrome: Hypertension: Systolic blood pressure (maximum) of 130 mmHg or higher, or diastolic blood pressure (minimum) of 85 mmHg or higher, or taking antihypertensive medication Dyslipidemia: Triglycerides of 150 mg/dL or higher, or HDL cholesterol below 40 mg/dL, or taking lipid-lowering medication Hyperglycemia: Fasting blood glucose of 110 mg/dL or higher, or HbA1c of 6.0% or higher, or currently taking medication for diabetes 5) Individuals capable of undergoing and participating in physical measurements and fitness tests 6) Individuals who have provided informed consent to participate in the study 7) Individuals who have been approved to participate by their attending physician or other medical professional
Exclusion criteria
Exclusion criteria: Individuals who are pregnant or breastfeeding, those with severe liver or kidney dysfunction, and those who have been hospitalized or undergone surgery for an orthopedic condition within the past three months are excluded. In addition, individuals deemed unsuitable by the principal investigator or co-investigators will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight change: Compare the difference in mean change in weight between the assigned groups at baseline before the intervention and at the end of the program (3 months). | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist circumference, blood pressure, lipids, blood glucose, urine sodium-to-potassium ratio: Compare the difference in mean change between treatment groups for secondary outcomes at baseline and 3 months. | — |
Countries
Japan
Contacts
Public ContactRumi Tsukinoki
Science Tokyo Department of Public Health Nursing
Outcome results
None listed